Shulgau, Z., Kamyshanskiy , Y., & Gulyayev, A. (2023). POSSIBILITIES OF USING MEDICINES AND BIOLOGICALLY ACTIVE SUBSTANCES AS CORRECTIVES FOR THE FORMATION OF PULMONARY FIBROSIS DURING SARS-COV-2 INFECTION AND IN THE POST-COVID PERIOD. Eurasian Journal of Applied Biotechnology, (1), 3–26. https://doi.org/10.11134/btp.1.2023.1